Bohao Zhang

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention.

Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention.

Journal: Frontiers in immunology

Published: March 24, 2026

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as encephalitis and concurrent Epstein-Barr virus detection: a case series.

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as encephalitis and concurrent Epstein-Barr virus detection: a case series.

Journal: Frontiers in immunology

Published: January 15, 2026

Maternal NKG2D-mediated immune activation shapes fetal neural development.

Maternal NKG2D-mediated immune activation shapes fetal neural development.

Journal: Molecular psychiatry

Published: January 14, 2026

Apelin-13 ameliorates hypoxic-ischemic brain damage and improves neurological function in neonatal rats by attenuating neuroinflammation via AMPK activation.

Apelin-13 ameliorates hypoxic-ischemic brain damage and improves neurological function in neonatal rats by attenuating neuroinflammation via AMPK activation.

Journal: International immunopharmacology

Published: September 26, 2025

The assessment of caregiver burden and associated factors on the primary family caregivers for patients with moyamoya disease: a cross-sectional study.

The assessment of caregiver burden and associated factors on the primary family caregivers for patients with moyamoya disease: a cross-sectional study.

Journal: Frontiers in psychiatry

Published: August 19, 2025

Selenium improves behavioral performance in a rat model of autism spectrum disorder by mitigating oxidative stress and modulating the Sirt1/Keap1/Nrf2/HO-1 signaling pathway.

Selenium improves behavioral performance in a rat model of autism spectrum disorder by mitigating oxidative stress and modulating the Sirt1/Keap1/Nrf2/HO-1 signaling pathway.

Journal: International immunopharmacology

Published: May 28, 2025

Identifying pyroptosis-hub genes and immune infiltration in neonatal hypoxic-ischemic brain injury.

Identifying pyroptosis-hub genes and immune infiltration in neonatal hypoxic-ischemic brain injury.

Journal: Frontiers in immunology

Published: April 22, 2025

Preliminary feasibility study on DTI to assess the early brain injury in germinal matrix-intraventricular hemorrhage rats.

Preliminary feasibility study on DTI to assess the early brain injury in germinal matrix-intraventricular hemorrhage rats.

Journal: Scientific reports

Published: December 19, 2024

The increase in the expression of circRNAs may contributes to a poor prognosis in acute myeloid leukemia: A systematic review and meta-analysis.

The increase in the expression of circRNAs may contributes to a poor prognosis in acute myeloid leukemia: A systematic review and meta-analysis.

Journal: Leukemia research

Published: October 30, 2024

Research progress on melatonin, 5-HT, and orexin in sleep disorders of children with autism spectrum disorder.

Research progress on melatonin, 5-HT, and orexin in sleep disorders of children with autism spectrum disorder.

Journal: Biomolecules & biomedicine

Published: August 23, 2024

Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers.

Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers.

Journal: Oncogene

Published: July 09, 2024

A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer.

A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer.

Journal: Frontiers in bioscience (Landmark edition)

Published: June 30, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026